Introduction:Basic information about CAS 4936-47-4|Nifuratel, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Nifuratel |
|---|
| CAS Number | 4936-47-4 | Molecular Weight | 285.276 |
|---|
| Density | 1.6±0.1 g/cm3 | Boiling Point | 423.6±53.0 °C at 760 mmHg |
|---|
| Molecular Formula | C10H11N3O5S | Melting Point | 176-178°C |
|---|
| MSDS | / | Flash Point | 210.0±30.9 °C |
|---|
Names
| Name | Nifuratel |
|---|
| Synonym | More Synonyms |
|---|
Nifuratel BiologicalActivity
| Description | Nifuratel(NF 113, SAP 113) is a broad antibacterial spectrum agent, which is used as an antibacterial, antifungal, and antiprotozoal (Trichomonas).IC50 Value: 0.125-1 μg/mL(MIC, A. vaginae) [1]Target: Antibacterial; Antiprotozoal in vitro: In vitro, nifuratel is able to inhibit the growth of A. vaginae, with a MIC range of 0.125-1 μg/mL; it is active against G. vaginalis and does not affect lactobacilli [1].in vivo: Patients were randomized to receive a 2-week course of bismuth subcitrate (8 mg/kg/day, q.d.s.), amoxicillin (50 mg/kg/day, q.d.s.), with either nifuratel (15 mg/kg/day, q.d.s.) or furazolidone (10 mg/kg/day, q.d.s.), plus omeprazole (0.5 mg/kg, once daily) [2].Toxicity: There were no serious adverse reactions and were no withdrawals due to any side-effects. All of side-effects were self-limiting (dark stools, urine discoloration, blackening of the tongue, and others) [3].Clinical trial: / |
|---|
| Related Catalog | Signaling Pathways >>Anti-infection >>BacterialSignaling Pathways >>Anti-infection >>ParasiteNatural Products >>AlkaloidResearch Areas >>Infection |
|---|
| References | [1]. Polatti F. Bacterial vaginosis, Atopobium vaginae and nifuratel. Curr Clin Pharmacol. 2012 Feb 1;7(1):36-40. [2]. Nijevitch AA, et al. Helicobacter pylori eradication in childhood after failure of initial treatment: advantage of quadruple therapy withnifuratel to furazolidone. Aliment Pharmacol Ther. 2005 Nov 1;22(9):881-7. [3]. Nijevitch AA, et al. Nifuratel-containing initial anti-Helicobacter pylori triple therapy in children. Helicobacter. 2007 Apr;12(2):132-5. |
|---|
Chemical & Physical Properties
| Density | 1.6±0.1 g/cm3 |
|---|
| Boiling Point | 423.6±53.0 °C at 760 mmHg |
|---|
| Melting Point | 176-178°C |
|---|
| Molecular Formula | C10H11N3O5S |
|---|
| Molecular Weight | 285.276 |
|---|
| Flash Point | 210.0±30.9 °C |
|---|
| Exact Mass | 285.041931 |
|---|
| PSA | 126.16000 |
|---|
| LogP | 0.27 |
|---|
| Vapour Pressure | 0.0±1.0 mmHg at 25°C |
|---|
| Index of Refraction | 1.666 |
|---|
| InChIKey | SRQKTCXJCCHINN-UHFFFAOYSA-N |
|---|
| SMILES | CSCC1CN(N=Cc2ccc([N+](=O)[O-])o2)C(=O)O1 |
|---|
| Storage condition | -20°C Freezer |
|---|
Toxicological Information
CHEMICAL IDENTIFICATION - RTECS NUMBER :
- RQ3590000
- CHEMICAL NAME :
- 2-Oxazolidinone, 5-((methylthio)methyl)-3-((5-nitrofurfurylidine)amino )-
- CAS REGISTRY NUMBER :
- 4936-47-4
- LAST UPDATED :
- 199612
- DATA ITEMS CITED :
- 3
- MOLECULAR FORMULA :
- C10-H11-N3-O5-S
- MOLECULAR WEIGHT :
- 285.30
- WISWESSER LINE NOTATION :
- T5OJ BNW E1UN- AT5NVOTJ E1S1
HEALTH HAZARD DATAACUTE TOXICITY DATA - TYPE OF TEST :
- LDLo - Lowest published lethal dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- >5 gm/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- >4500 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
MUTATION DATA - TYPE OF TEST :
- Mutation in microorganisms
- TEST SYSTEM :
- Bacteria - Salmonella typhimurium
- DOSE/DURATION :
- 50 ng/plate
- REFERENCE :
- MIGIA6 Minerva Ginecologia. (Edizioni Minerva Medica, Casella Postale 491, I-10126 Turin, Italy) V.1- 1949- Volume(issue)/page/year: 31,263,1979
|
Safety Information
| Hazard Codes | Xi |
|---|
| Risk Phrases | R36/37/38:Irritating to eyes, respiratory system and skin . |
|---|
| Safety Phrases | S26-S36-S37/39 |
|---|
| WGK Germany | 3 |
|---|
Synonyms
| 5-[(Methylthio)methyl]-3-[(5-nitrofurfurylidene)amino]-2-oxazolidinone |
| Polmiror |
| UNII:U60U6P08SP |
| nf113 |
| EINECS 225-576-2 |
| 5-[(Methylsulfanyl)methyl]-3-{(E)-[(5-nitro-2-furyl)methylene]amino}-1,3-oxazolidin-2-one |
| Magmilor |
| 5-(methylthiomethyl)-3-((5-nitrofuran-2-yl)methyleneamino)oxazolidin-2-one |
| Nifuratel |
| Methylmercadone |
| Tydantil |
| 2-Oxazolidinone, 5-((methylthio)methyl)-3-(((5-nitro-2-furanyl)methylene)amino)- |
| Macmiror |
| Omnes |
| MFCD00057257 |
| sap113 |
| 5-(Methylmercaptomethyl)-3-(5-nitro-2-furfurylideneamino)-2-oxazolidinone |
| 5-[(Methylthio)methyl]-3-[[(5-nitro-2-furanyl)methylene]amino]-2-oxazolidinone |
| Inimur |
| 2-Oxazolidinone, 5-[(methylthio)methyl]-3-[[(1E)-(5-nitro-2-furanyl)methylene]amino]- |
| 5-((Methylthio)methyl)-3-((5-nitrofurfurylidene)amino)-2-oxazolidinone |
| 5-[(Methylsulfanyl)methyl]-3-{[(E)-(5-nitro-2-furyl)methylene]amino}-1,3-oxazolidin-2-one |